Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P White

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Toxicology Letters|February 1, 1987
Circadian variations in hepatic glutathione content, gamma-glutamylcysteine synthetase and gamma-glutamyl transferase activities in miceB P White, M H Davies, R C Schnell
Australian Dental Journal|September 12, 2015
The Australian litigation landscape - oral and maxillofacial surgery and general dentistry (oral surgery procedures): an analysis of litigation casesE K Badenoch-Jones, B P White, A J Lynham
Human Gene Therapy|December 28, 1999
Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: applications for cardiovascular gene therapyP Houston, B P White, C J Campbell, et al.
British Journal of Pharmacology|February 1, 1991
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human plateletsI S Watts, K A Wharton, B P White, et al.
British Journal of Pharmacology|December 1, 1989
Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivoI S Watts, B P White, K A Wharton, et al.
Clinical and Experimental Immunology|April 1, 1978
Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the diseaseA R Mackenzie, C R Pick, P R Sibley, et al.
Developmental Psychobiology|December 10, 1998
Dampening of the cortisol response to handling at 3 months in human infants and its relation to sleep, circadian cortisol activity, and behavioral distressM C Larson, B P White, A Cochran, et al.
Child Development|October 4, 2000
Behavioral and physiological responsivity, sleep, and patterns of daily cortisol production in infants with and without colicB P White, M R Gunnar, M C Larson, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirinP Lumley, R J Keery, K A Wharton, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Toxicology Letters|February 1, 1987
Circadian variations in hepatic glutathione content, gamma-glutamylcysteine synthetase and gamma-glutamyl transferase activities in miceB P White, M H Davies, R C Schnell
Australian Dental Journal|September 12, 2015
The Australian litigation landscape - oral and maxillofacial surgery and general dentistry (oral surgery procedures): an analysis of litigation casesE K Badenoch-Jones, B P White, A J Lynham
Human Gene Therapy|December 28, 1999
Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: applications for cardiovascular gene therapyP Houston, B P White, C J Campbell, et al.
British Journal of Pharmacology|February 1, 1991
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human plateletsI S Watts, K A Wharton, B P White, et al.
British Journal of Pharmacology|December 1, 1989
Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivoI S Watts, B P White, K A Wharton, et al.
Clinical and Experimental Immunology|April 1, 1978
Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the diseaseA R Mackenzie, C R Pick, P R Sibley, et al.
Developmental Psychobiology|December 10, 1998
Dampening of the cortisol response to handling at 3 months in human infants and its relation to sleep, circadian cortisol activity, and behavioral distressM C Larson, B P White, A Cochran, et al.
Child Development|October 4, 2000
Behavioral and physiological responsivity, sleep, and patterns of daily cortisol production in infants with and without colicB P White, M R Gunnar, M C Larson, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirinP Lumley, R J Keery, K A Wharton, et al.
Pageof 2